Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Share-based Compensation (2018 - 2026)

Viemed Healthcare filings provide 8 years of Share-based Compensation readings, the most recent being $2.3 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 51.22% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.1 million, a 45.3% increase, with the full-year FY2025 number at $9.1 million, up 45.3% from a year prior.
  • Share-based Compensation hit $2.3 million in Q4 2025 for Viemed Healthcare, up from $2.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.3 million in Q2 2025 to a low of $1.2 million in Q2 2021.
  • Median Share-based Compensation over the past 5 years was $1.4 million (2023), compared with a mean of $1.6 million.
  • Biggest five-year swings in Share-based Compensation: fell 0.85% in 2024 and later surged 61.38% in 2025.
  • Viemed Healthcare's Share-based Compensation stood at $1.3 million in 2021, then increased by 0.92% to $1.3 million in 2022, then increased by 16.48% to $1.5 million in 2023, then decreased by 0.85% to $1.5 million in 2024, then soared by 51.22% to $2.3 million in 2025.
  • The last three reported values for Share-based Compensation were $2.3 million (Q4 2025), $2.2 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.